CD33 and Splenomegaly: More importantly, c-MYChighMYCBP2low patients showed higher median WBC counts, higher percentage of CD34(+) and CD33(+) cells, higher rate of splenomegaly, liver infiltration, increased LDH, and lower CR rate compared with that of c-MYClowMYCBP2high patients.